127 related articles for article (PubMed ID: 10739004)
1. CD14+ peripheral blood mononuclear cells from chronic myeloid leukemia and normal donors are inhibitory to short- and long-term cultured colony-forming cells.
Heissig B; Pasternak G; Hörner S; Schwerdtfeger R; Rossol S; Hehlmann R
Leuk Res; 2000 Mar; 24(3):217-31. PubMed ID: 10739004
[TBL] [Abstract][Full Text] [Related]
2. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.
Cervantes F; Pierson BA; McGlave PB; Verfaillie CM; Miller JS
Blood; 1996 Mar; 87(6):2476-85. PubMed ID: 8630414
[TBL] [Abstract][Full Text] [Related]
3. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.
Bhatia R; Munthe HA; Williams AD; Zhang F; Forman SJ; Slovak ML
Exp Hematol; 2000 Dec; 28(12):1401-12. PubMed ID: 11146162
[TBL] [Abstract][Full Text] [Related]
4. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.
Bhatia R; McGlave PB; Dewald GW; Blazar BR; Verfaillie CM
Blood; 1995 Jun; 85(12):3636-45. PubMed ID: 7780147
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia.
Bhatia R; McCarthy JB; Verfaillie CM
Blood; 1996 May; 87(9):3883-91. PubMed ID: 8611716
[TBL] [Abstract][Full Text] [Related]
6. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia.
Petzer AL; Eaves CJ; Barnett MJ; Eaves AC
Blood; 1997 Jul; 90(1):64-9. PubMed ID: 9207439
[TBL] [Abstract][Full Text] [Related]
7. Activation of beta1 integrins on CML progenitors reveals cooperation between beta1 integrins and CD44 in the regulation of adhesion and proliferation.
Lundell BI; McCarthy JB; Kovach NL; Verfaillie CM
Leukemia; 1997 Jun; 11(6):822-9. PubMed ID: 9177435
[TBL] [Abstract][Full Text] [Related]
8. Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors.
Kasper B; Fruehauf S; Schiedlmeier B; Buchdunger E; Ho AD; Zeller WJ
Cancer Chemother Pharmacol; 1999; 44(5):433-8. PubMed ID: 10501919
[TBL] [Abstract][Full Text] [Related]
9. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.
Bernstein ID; Singer JW; Smith FO; Andrews RG; Flowers DA; Petersens J; Steinmann L; Najfeld V; Savage D; Fruchtman S
Blood; 1992 Apr; 79(7):1811-6. PubMed ID: 1373089
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
11. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
[TBL] [Abstract][Full Text] [Related]
12. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
[TBL] [Abstract][Full Text] [Related]
13. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.
Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E
J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures.
Luna-Bautista F; Sánchez-Valle E; Ayala-Sánchez M; Morales-Polanco M; Meillon-García L; Benítez-Bribiesca L; Mayani H
Hematology; 2003 Jun; 8(3):155-63. PubMed ID: 12745649
[TBL] [Abstract][Full Text] [Related]
16. Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic progenitor cells.
Sparrow RL; O'Flaherty E; Blanksby TM; Szer J; Van Der Weyden MB
Leuk Res; 1997 Jan; 21(1):29-36. PubMed ID: 9029183
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia.
Selleri C; Sato T; Del Vecchio L; Luciano L; Barrett AJ; Rotoli B; Young NS; Maciejewski JP
Blood; 1997 Feb; 89(3):957-64. PubMed ID: 9028327
[TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines.
Ailles LE; Gerhard B; Hogge DE
Blood; 1997 Oct; 90(7):2555-64. PubMed ID: 9326221
[TBL] [Abstract][Full Text] [Related]
19. Abnormal growth factor modulation of beta1-integrin-mediated adhesion in chronic myelogenous leukaemia haematopoietic progenitors.
Bhatia R; Munthe HA; Forman SJ
Br J Haematol; 2001 Dec; 115(4):845-53. PubMed ID: 11843818
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous exodus of high numbers of normal early progenitor cells (Ph-negative LTC-IC) in the peripheral blood of patients with chronic myeloid leukaemia at the beginning of the disease.
Podestà M; Piaggio G; Sessarego M; Pitto A; Benvenuto F; Vassallo F; Fugazza G; Carella AM; Frassoni F
Br J Haematol; 1997 Apr; 97(1):94-8. PubMed ID: 9136946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]